Interestingly, demographical data suggest an increased incidence of cancer in individuals with a germline G2019S LRRK2 mutation, in particular, melanoma [27,28,29,30]; however, findings are not consistent across all studies [31,32]. This evidence concerns the gene LRRK2 and cancer.